Drug Information

Drug General Information
Drug ID
D0A2SK
Former ID
DNC013505
Drug Name
(Z)-1-(pyridazin-3-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529193]
Structure
Download
2D MOL

3D MOL
Formula
C22H36N2O
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NN=CC=C1
InChI
1S/C22H36N2O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-22(25)21-18-17-20-23-24-21/h9-10,17-18,20H,2-8,11-16,19H2,1H3/b10-9-
InChIKey
REQRZXMTFPJHJQ-KTKRTIGZSA-N
PubChem Compound ID
12071714
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529193]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.